Celanese Stock News

It's always a good idea to keep your wish list ready by separating the wheat from the chaff. What are 5 safe and cheap dividend stocks to invest? Find out.

Monthly update of the Dividend Champions List. 139 companies declared higher dividends in the past month, with an average increase of 10.54% over their previous payouts.

Celanese Corporation Celanese C found using ticker (CE) have now 20 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 225 and 140 and has a mean target at 188.05. Now with the previous closing price of 141.28 this would indicate that there is a potential upside of 33.1%. There is a 50 day moving average of 160.58 and the 200 day MA is 158.92. The company has a market cap of $15,046m. Company Website: https://www.celanese.com [stock_market_widget type="chart" template="basic" color="green" assets=CE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,027m based on the market concensus. Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain.

Although US stocks closed mixed on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock

Artisan Partners, a high value-added investment management firm, published its “Artisan Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

WASHINGTON, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The Global Medical Polymers Market size is expected to reach USD 32.5 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 9.3% during the forecast period. Medical Polymers are used in the manufacturing of medical devices and packaging, the sturdy growth in pharmaceuticals in past years led to an increased demand for Medical Polymers and subsequently boosting the marker growth, states Vantage Market Research, in a report, titled "Medical Polymers Market by Product (Medical resins & fibers, Medical elastomers, Biodegradable plastics), by Application (Medical equipment & devices, Medical packaging, Others), by Region (North America, Europe, Asia-Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028) ". The market size valued at USD 16.5 Billion in 2021. Please Check Out Our Free Sample Reports and Make a More Informed Decision: Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/medical-polymers-market-1210/request-sample (Sample reports are a great way to test our in-depth reports or study before you make a purchase) The newly updated, 160+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.

Wall Street analysts are constantly releasing and updating reports on stocks across their respective coverage universes.

Major players in the cellulose acetate market are Eastman Chemical Company, Solvay S. A. , Celanese Corporation, Daicel Corporation, Mitsubishi Chemical Holdings, Sichuan Push Acetati Co. Ltd, Rayonier Advanced Materials Inc. Major players in the cellulose acetate market are Eastman Chemical Company, Solvay S. A. , Celanese Corporation, Daicel Corporation, Mitsubishi Chemical Holdings, Sichuan Push Acetati Co. Ltd, Rayonier Advanced Materials Inc.

Fjärde kvartalet 2021

HOUSTON (ICIS)--Celanese is targeting a price increase of 8 cents/lb on its US vinyl acetate monomer (VAM), effective 1 March or as contracts allow, according to a customer letter. A similar increase

Analysts have provided the following ratings for Celanese (NYSE:CE) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 3 1 0 Last 30D 1

Over the past 3 months, 7 analysts have published their opinion on Celanese (NYSE:CE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's

Over the past 3 months, 7 analysts have published their opinion on Celanese (NYSE: CE ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 3 1 0 Last 30D 1 0 0 1 0 1M Ago 0 2 1 0 0 2M Ago 0 0 1 0 0 3M Ago 0 0 1 0 0 According to 7 analyst offering 12-month price targets in the last 3 months, Celanese has an average price target of $177.86 with a high of $206.00 and a low of Full story available on Benzinga.com

DuPont's (DD) latest deal strengthens its foothold in the fields of electronics, water, industrial technologies, protection and next-gen automotive.

Wells Fargo lowered DraftKings Inc. (NASDAQ: DKNG) price target from $41 to $19. DraftKings shares dropped 5.8% to $16.28 in pre-market trading. Credit Suisse cut the price target on MercadoLibre,